Does sex affect the efficacy of systemic pharmacological treatments of pain in knee osteoarthritis? A systematic review.

Using the average change in pain from baseline (10-point VAS pain scale) as the primary efficacy endpoint, numerically larger reductions in pain for tapentadol PR versus placebo were observed but did not reach statistical significance (P ​= ​0.152).

also in 111,027 other papers